Characterization of solid lipid nanoparticles produced with carnauba wax for rosmarinic acid oral delivery

被引:65
|
作者
Madureira, Ana Raquel [1 ]
Campos, Debora A. [1 ]
Fonte, Pedro [2 ]
Nunes, Sara [3 ]
Reis, Flavio [3 ]
Gomes, Ana Maria [1 ]
Sarmento, Bruno [2 ,4 ,5 ]
Pintado, Maria Manuela [1 ]
机构
[1] Univ Catolica Portuguesa, CBQF, Escola Super Biotecnol, Lab Associado, P-4202401 Porto, Portugal
[2] Inst Invest & Form Avancada Ciencias & Tecnol Sau, CESPU, P-4585116 Gandra PRD, Portugal
[3] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci, IBILI,Lab Pharmacol & Expt Therapeut,Sub Unit 1, P-3000548 Coimbra, Portugal
[4] Inst Invest & Inovacao Saude, I3S, P-4150180 Porto, Portugal
[5] Univ Porto, Inst Biomed Engn, INEB, P-4150180 Porto, Portugal
关键词
PARAMETERS; PHASE;
D O I
10.1039/c4ra15802d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the last decade, research studies have increased on the development of delivery systems for polyphenols, for protection, improvement of stability and increase of their bioavailability. Rosmarinic acid is a polyphenol with described bioactivities, such as antioxidant, anti-mutagenic, anti-bacterial and anti-viral capabilities. Thus, the aim of this research work was to produce stable solid lipid nanoparticles (SLN) using carnauba wax as lipidic matrix, for delivery of rosmarinic acid, to be further incorporated into food matrices. Hence, different concentrations of wax (0.5, 1 and 1.5%, w/v) and percentages of surfactant (1, 2 and 3%, v/v) were tested. Physical properties, surface morphology and association efficiencies were studied at time of production and after 28 day at refrigerated storage. Thermal properties and the nature of the chemical interactions between the lipids waxes and rosmarinic acid were also evaluated. The particles showed range size between 35-927 nm and zeta potentials of ca. -38 to 40, showing high stability, with no risk of aggregation due to electric repulsion of SLN. High association efficiencies % (ca. 99%) were obtained. FTIR analyses proved the association of rosmarinic acid and lipidic matrix. The low lipid and high surfactant concentrations leads to small SLN. The surfactant, polysorbate 80 decreases the interfacial tension in the SLN surfaces, preventing aggregation, leading to the development of small particles. These properties were maintained throughout the 28 day of refrigerated storage, and no rosmarinic acid was released by the particles during refrigeration, indicating good compatibility between rosmarinic acid and the waxy core of SLN. The optimum range values to obtain the desirable features for incorporation in a functional food suggest formulations containing 1.0 and 1.5% (w/v) of lipid and 2% (v/v) of surfactant.
引用
收藏
页码:22665 / 22673
页数:9
相关论文
共 50 条
  • [21] Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics
    Suri, Kanika
    Pfeifer, Liam
    Cvet, Donna
    Li, Angela
    McCoy, Michael
    Singh, Amit
    Amiji, Mansoor M.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2024, : 1755 - 1769
  • [22] Characterization of Solid Lipid Nanoparticles to improve liposoluble drug delivery
    Arana, L.
    Goni, F. M.
    Alkorta, I.
    FEBS JOURNAL, 2015, 282 : 250 - 250
  • [23] Solid lipid nanoparticles of stearic acid for the drug delivery of paliperidone
    Kumar, Sacheen
    Randhawa, Jaspreet Kaur
    RSC ADVANCES, 2015, 5 (84): : 68743 - 68750
  • [24] Preparation and characterization of carnauba wax nanostructured lipid carriers containing benzophenone-3
    Lacerda, S. P.
    Cerize, N. N. P.
    Re, M. I.
    INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2011, 33 (04) : 312 - 321
  • [25] Investigation of solid lipid nanoparticles as oral delivery of Paclitaxel for enhanced absorption
    Desai, Jagruti
    Patel, Swayamprakash
    Manjappa, Arehalli
    Patel, Alkesh
    Patel, Twinkle
    JOURNAL OF RESEARCH IN PHARMACY, 2024, 28 (03): : 781 - 796
  • [26] Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery
    Rawat, Manoj K.
    Jain, Achint
    Mishra, Amit
    Muthu, Madaswamy S.
    Singh, Sanjay
    THERAPEUTIC DELIVERY, 2010, 1 (01) : 63 - 73
  • [27] The characterization of ascorbic acid loaded solid lipid nanoparticles
    Dikmen, G.
    Guney, G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S206 - S207
  • [28] Comparison of wax and glyceride solid lipid nanoparticles (SLN®)
    Jenning, V
    Gohla, S
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) : 219 - 222
  • [29] Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH
    Hallan, Supandeep Singh
    Nidhi
    Kaur, Veerpal
    Jain, Vikas
    Mishra, Neeraj
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2017, 45 (08) : 1631 - 1639
  • [30] Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery
    Sgorla, Debora
    Lechanteur, Anna
    Almeida, Andreia
    Sousa, Flavia
    Melo, Eduardo
    Bunhak, Elcio
    Mainardes, Rubiana
    Khalil, Najeh
    Cavalcanti, Osvaldo
    Sarmento, Bruno
    EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (03) : 213 - 222